tradingkey.logo
tradingkey.logo
Search

Fibrobiologics Announces Release Of Cywc628 Drug Product For Phase 1/2 Diabetic Foot Ulcer Clinical Trial

ReutersMay 4, 2026 12:33 PM
facebooktwitterlinkedin
View all comments0

- Fibrobiologics Inc FBLG.O:

  • FIBROBIOLOGICS ANNOUNCES RELEASE OF CYWC628 DRUG PRODUCT FOR PHASE 1/2 DIABETIC FOOT ULCER CLINICAL TRIAL

  • FIBROBIOLOGICS INC - PHASE 1/2 TRIAL TO EVALUATE CYWC628 SAFETY, TOLERABILITY, AND EFFICACY IN DFU PATIENTS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI